178 related articles for article (PubMed ID: 36503048)
1. CircSETD3 mediates acquired resistance to gefitinib in non-small lung cancer cells by FXR1/ECT2 pathway. Wen C; Li Y; Huang Y; Wang N; He S; Bao M; Zhou H; Wu L Int J Biochem Cell Biol; 2023 Jan; 154():106344. PubMed ID: 36503048 [TBL] [Abstract][Full Text] [Related]
2. ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. Zhao L; Wang Y; Sun X; Zhang X; Simone N; He J Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397056 [TBL] [Abstract][Full Text] [Related]
3. Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance. Thorac Cancer; ; . PubMed ID: 31777195 [TBL] [Abstract][Full Text] [Related]